Esquire Financial director sells 3,000 shares

Esquire Financial Holdings, Inc. director Robert Mitzman reported a sale of 3,000 shares of common stock on July 30, 2026 in a transaction coded as a sale in an open market or private transaction at $129.5973 per share.

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. director Robert Mitzman reported a sale of 3,000 shares of common stock on July 30, 2026 in a transaction coded as a sale in an open market or private transaction at $129.5973 per share. Following this sale, he directly holds 139,679 shares of common stock, which include multiple grants of restricted stock that vest between December 2024 and December 2027. He also holds 2,500 shares indirectly through an insurance trust I and 2,500 shares indirectly through an insurance trust II.

Insider Trade Summary

Net Seller: 3,000 shares

Net Sell 3 txns

Insider Mitzman Robert

Role Director

Sold 3,000 shs ($389K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2, F3, F4, F5, F6	3,000	$129.5973	$389K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 139,679 shares (Direct); Common Stock — 2,500 shares (Indirect, By insurance trust I); Common Stock — 2,500 shares (Indirect, By insurance trust II)

Footnotes (6)

1. F1. Includes shares of restricted stock which vest 100% on December 10, 2026.
2. F2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
3. F3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
4. F4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
5. F5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.
6. F6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

Key Figures

Shares sold: 3000.0000 shares Sale price: $129.5973 per share Direct holdings after sale: 139679.0000 shares +3 more

6 metrics

Shares sold 3000.0000 shares Common stock sold by director on July 30, 2026

Sale price $129.5973 per share Price for 3,000 ESQ shares sold on July 30, 2026

Direct holdings after sale 139679.0000 shares Common stock directly held by director following the transaction

Indirect holdings insurance trust I 2500.0000 shares Common stock held indirectly through insurance trust I

Indirect holdings insurance trust II 2500.0000 shares Common stock held indirectly through insurance trust II

Net buy/sell shares -3000 shares Net effect of reported insider common stock transactions

Key Terms

restricted stock, indirect, insurance trust, sale in open market or private transaction

4 terms

restricted stock financial

"Includes shares of restricted stock which vest 100% on December 10, 2026."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

indirect financial

"direct_or_indirect: "I", nature_of_ownership: "By insurance trust I""

insurance trust financial

"nature_of_ownership: "By insurance trust II""

sale in open market or private transaction financial

"transaction_code_description: "Sale in open market or private transaction""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Esquire Financial (ESQ) disclose for July 30, 2026?

Esquire Financial (ESQ) disclosed that director Robert Mitzman sold 3,000 shares of common stock on July 30, 2026 at $129.5973 per share in a sale coded as an open market or private transaction.

How many ESQ shares does director Robert Mitzman hold after the reported sale?

After the transaction, director Robert Mitzman directly holds 139,679 ESQ shares of common stock. This direct position includes several grants of restricted stock scheduled to vest between December 2024 and December 2027.

What was the price per share in the Esquire Financial (ESQ) insider sale?

The 3,000-share sale by Esquire Financial (ESQ) director Robert Mitzman on July 30, 2026 was executed at $129.5973 per share. The transaction is reported as a sale in an open market or private transaction.

Does the Esquire Financial (ESQ) director hold any indirect shares after the sale?

Yes. In addition to his direct holdings, the Esquire Financial (ESQ) director holds 2,500 shares indirectly through insurance trust I and another 2,500 shares indirectly through insurance trust II as of July 30, 2026.

What restricted stock vesting schedule is associated with the ESQ director’s holdings?

The ESQ director’s direct holdings include restricted stock that vests 100% on December 10, 2026 and in three equal annual installments beginning on December 16, 2024; December 9, 2025; December 19, 2026; December 3, 2027; and December 15, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 12:14 PM Accepted by SEC EDGAR 08/03/2026 - 12:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mitzman Robert

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NEW YORK 11753

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/30/2026		S		3,000	D	$129.5973	139,679(1)(2)(3)(4)(5)(6)	D
Common Stock								2,500	I	By insurance trust I
Common Stock								2,500	I	By insurance trust II

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes shares of restricted stock which vest 100% on December 10, 2026.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

	/s/ Gary A. Lax, pursuant to power of attorney	08/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)